Background
Pancreatic cancer, currently one of the most lethal human malignancies [1] , is largely refractory to conventional therapies. Peroxisome proliferator-activated receptor alpha (PPARa), a member of the PPAR family [2] , regulating tumorigenesis [3] , is a ligand-activated transcription factor [4] . Caspase-3 is encoded by the CASP3 gene [5] , as a potential therapeutic target for cancer patients [6] and plays key roles in the growth stimulation.
(-)-Epigallocatechin-3-gallate (EGCG) (C 22 H 18 O 11 ; Figure 1A ), found in green tea [7] , which is widely consumed in China [8] , is one of the most abundant and powerful catechins [9] Figure 1B ), a selective inhibitor of rho-associated protein kinase 1 (ROCK1) [10] , is widely used in treating cardiovascular disease [11] , inflammation [12] , and cancer [13] . Although Y-27632 [14] [15] [16] and EGCG [17] [18] [19] inhibit the growth of many cancer cells, whether the efficacy of Y-27632 increases the sensitivity of PANC-1 cells to EGCG is not yet clear. The present study hypothesized that the combination of Y-27632 and EGCG would reveal additive inhibitory effects in vitro.
In the present study, the capacity of Y-27632 to sensitize PANC-1 cells to the effects of EGCG in regulating cell proliferation and migration was investigated. Furthermore, the expression of PPARa mRNA and caspase-3 mRNA in EGCG and Y-27632 alone, and in EGCG combined with Y-27632 on PANC-1 cells, was examined.
Material and Methods
Cell culture PANC-1 cells (SIBCB, Shanghai, China) were maintained in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco BRL, MD, USA) (15) supplemented with 10% fetal bovine serum (Gibco BRL, MD, USA) and penicillin (100 U/mL)-streptomycin (100 mg/mL) (Gibco BRL, MD, USA) in a humidified atmosphere containing 5% CO 2 and 95% air at 37°C.
Cell proliferation assay
PANC-1 cells (1×10 6 /well) were seeded into 96-well plates (Corning, NY, USA). These cells were then treated with dimethyl sulfoxide (DMSO) (control) as well as different concentrations (20, 40, 60 , and 80 μg/mL) of EGCG (NICPBP, Beijing, China) for 48 h. In addition, PANC-1 cells were treated separately with DMSO (control), 60 μg/mL EGCG, 20 μM Y-27632, and EGCG combined with Y-27632 (60 μg/mL EGCG + 20 μM Y-27632) for 48 h. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) [16] as described in a previous study. The absorbance (A) of each hole in the 96-well plate was determined at 475 nm using a microplate reader, using the formula:
(control), 60 μg/mL EGCG, 20 μM Y-27632, and EGCG combin μg/mL EGCG + 20 μM Y-27632) for 48 h. Cell viability was as Counting Kit-8 (CCK-8) (16) as described in a previous study. T each hole in the 96-well plate was determined at 475 nm using using the formula: Forward: 5'-CATGGAAGCGAATCAATGGACT-3' and reverse: 5'-CTGTACCAGACCGAGATGTCA-3' for caspase-3 (139 bp). GAPDH was used as an internal control to evaluate the relative expression of PPARa. RT-qPCR reagents were purchased from TIANGEN Biotech (Beijing) Co., Ltd. (Beijing, China). Relative mRNA was calculated using the formula: 2-DDCt [20, 21] .
Statistical analysis
Data are shown as mean ± standard deviation. Statistical comparisons were performed using SPSS version 18.0 software (22) . P<0.05 was considered to be significant [23, 24] .
Results

Y-27632 augments the antiproliferative effect of EGCG in PANC-1 cells
The effect of EGCG and Y-27632 on the PANC-1 cell proliferation was evaluated using the CCK-8 assay. Different concentrations of EGCG (20, 40, 60 , and 80 μg/mL) inhibited cell viability in a dose-dependent manner ( Figure 1C ). EGCG (60 μg/ mL) inhibited PANC-1 cell viability by 69% ( Figure 1D ). Y-27632 (20 μM) inhibited PANC-1 cell viability by 17% ( Figure 1D ), and 60 μg/mL EGCG + 20 μM Y-27632 inhibited PANC-1 cell viability by 82% ( Figure 1D ). These results suggest that 20 μM Y-27632 enhanced the sensitivity of PANC-1 cells to 60 μg/mL EGCG and suppressed cell proliferation.
Y-27632 improved the anti-migration and apoptosis effect of EGCG in PANC-1 cells
The effect of 60 μg/mL EGCG on the PANC-1 cell migration in the presence of 20 μM Y-27632 was evaluated using transwell migration assays (Figure 2A ). Following treatment with 60 μg/mL EGCG + 20 μM Y-27632, the cell migration significantly decreased compared with that of the untreated PANC-1 control and the cells treated with 20 μM Y-27632 or 60 μg/ mL EGCG alone ( Figure 2B ). These data suggest that PANC-1 cell migration is inhibited by treatment with 60 μg/mL EGCG + 20 μM Y-27632. Under Hoechst 33258 staining (Figure 2C) , the normal PANC-1 cells without 60 μg/mL EGCG and 20 μM Y-27632 intervention were dark blue (control), but early apoptotic nuclei due to chromosomal collapse were stained bright blue in the 60 μg/mL EGCG and 20 μM Y-27632 treatment groups ( Figure 2C ), and were easily distinguished from the normal cells. Also, the number of bright blue-stained nuclei This study, using the CCK-8 assay, evaluated the probable effect of different concentrations of EGCG (20, 40, 60 , and 80 μg/mL) on PANC-1 cells. The results are in agreement with a previous study [25] , which showed that EGCG (20-80 μg/mL) inhibited the proliferation of PANC-1 cells in a dose-dependent manner.
The results also showed that at 48 h, Y-27632 enhanced the sensitivity of PANC-1 cells to EGCG and suppressed the proliferation of PANC-1 cells.
In the present study, using transwell migration assays and Hoechst 33258 staining, the effect of 20 μM Y-27632 combined with 60 μg/mL EGCG on the PANC-1 cell migration and apoptosis was evaluated. The results also showed that 20 μM Y-27632 enhanced the anti-migration effect of 60 μg/mL EGCG on PANC-1 cells when treated for 48 h. Furthermore, the effects of 60 μg/mL EGCG in regulating apoptosis of PANC-1 cells enhanced when treated with 20 μM Y-27632 + 60 μg/mL EGCG.
Tumor growth and metastasis depend on angiogenesis [26, 27] , and gene expression profiling of PPARa has been used in several studies [28, 29] , but a very few studies included pancreatic cancer. When PANC-1 cells were exposed to EGCG [30] , the expression of PPARa, a direct negative regulator of heme oxygenase (HO-1) activation by EGCG [31] , which confers cell susceptibility to EGCG, increased at the protein level in a dosedependent manner. EGCG induces apoptosis and inhibits the growth of PANC-1 tumors [32] and activates caspase-3 is a dose-dependent manner. Therefore, the capacity of Y-27632 to sensitize PANC-1 cells to EGCG by activated PPARa mRNA and caspase-3 mRNA expression were investigated. 
